Abstract: This disclosure relates to systems and methods for providing haptic feedback to a driver when aligning an electrified vehicle to charging equipment in preparation for charging events. Haptic feedback may be provided at the vehicle steering wheel to guide the driver on a correct travel path both laterally and longitudinally relative to the charging equipment. In some embodiments, the haptic feedback is provided at the steering wheel in the form of distinguishable pulsing patterns that alert the driver how the travel path should change for properly aligning the vehicle to the charging equipment. In other embodiments, the haptic feedback is provided in the form of tactile cues, such as making it more difficult for the driver to rotate the steering wheel in a direction that would render the vehicle less aligned to the charging equipment.

Abstract: A vehicle charging method includes, among other things, electrically connecting a first vehicle to a grid source, electrically connecting the first vehicle to a second vehicle, and charging a traction battery of the first vehicle using electricity from the second vehicle and electricity from the grid source. A vehicle charging system includes, among other things, a traction battery of a first vehicle, and a charger that is used to charge the traction battery using electricity from a grid source, electricity from a second vehicle, or both.

Abstract: This disclosure relates to electrified vehicle charging systems that are equipped with multiple charging interfaces. An exemplary charging system may include a first charging interface, a second charging interface, an on-board charger module operably coupled to the first and second charging interfaces, and a control module configured to command the second charging interface to be isolated from the on-board charger module in response to a status change of a door of the first charging interface. The status of the door may be monitored by a sensor system of the charging system for determining whether or not to disable the second charging interface.

Abstract: This disclosure describes charging systems for electrified vehicles. Exemplary charging systems may employ a multi-voltage charging circuit that supports charging of a traction battery pack at both a first voltage level during a first charging condition and a second, different voltage level during a second charging condition. Higher voltage levels may be experienced during the second charging condition as compared to the first charging condition.

Abstract: A power converter for an electric vehicle include a connection interface for coupling an external battery to a first bus. The power converter includes a first set of switching devices configured to transfer power between a charge port and the first bus, and a second set of switching devices configured to transfer power between the first bus and a second bus coupled to a traction battery. The power converter includes a controller programmed to control a voltage level of the first bus to different nominal operating voltages based in different operating modes.

Abstract: This disclosure describes electric vehicle supply equipment (EVSE) connectors for synchronizing and controlling charging between multiple electric vehicle supply equipment and an electrified vehicle. An exemplary EVSE connector is connectable to a charge port assembly of an electrified vehicle and includes a first port configured to receive a first charger coupler of a first EVSE and a second port configured to receive a second charger coupler of a second EVSE. The EVSE connector further includes a control system for coordinating charging operations between the first and second EVSE and the electrified vehicle.

Abstract: A system for a vehicle includes a bidirectional power converter, a vehicle controller configured to, in response to a pilot signal indicating a connection to a charging station, cause the converter to initiate power flow from the station to the vehicle, and an electric vehicle supply equipment (EVSE) controller configured to, in response to detecting a connection to another vehicle, generate the pilot signal to cause the converter to generate power to transfer to the another vehicle.

Abstract: A detected displacement of a marker on a vehicle is determined based on image data captured while the vehicle traverses a displacement object of a ground surface. Then a health status of a suspension component of the vehicle is determined to be unhealthy based on comparing the detected displacement of the marker to a target displacement of the marker. The target displacement specifies displacement of the marker that indicates the suspension component is healthy. The vehicle is operated based on the suspension component being unhealthy.

Abstract: An electrified vehicle includes a traction battery and a battery thermal control system. A controller is configured to receive an initial regenerative braking capability and operation the battery thermal control system to precondition the traction battery during a charge event to a temperature that corresponds to the initial regenerative braking capability such that, during a subsequent drive cycle, the regenerative braking capability is at least equal to the initial regenerative braking capability for at least a predetermined duration into the subsequent drive cycle.

Abstract: A power converter for an electric vehicle include a connection interface for coupling an external battery to a first bus. The power converter includes a first set of switching devices configured to transfer power between a charge port and the first bus, and a second set of switching devices configured to transfer power between the first bus and a second bus coupled to a traction battery. The power converter includes a controller programmed to control a voltage level of the first bus to different nominal operating voltages based in different operating modes.

Abstract: A system for a vehicle includes a bidirectional power converter, a vehicle controller configured to, in response to a pilot signal indicating a connection to a charging station, cause the converter to initiate power flow from the station to the vehicle, and an electric vehicle supply equipment (EVSE) controller configured to, in response to detecting a connection to another vehicle, generate the pilot signal to cause the converter to generate power to transfer to the another vehicle.

Abstract: A neural network architecture is disclosed for performing video frame prediction using a sequence of video frames and corresponding pairwise optical flows. The neural network processes the sequence of video frames and optical flows utilizing three-dimensional convolution operations, where time (or multiple video frames in the sequence of video frames) provides the third dimension in addition to the two-dimensional pixel space of the video frames. The neural network generates a set of parameters used to predict a next video frame in the sequence of video frames by sampling a previous video frame utilizing spatially-displaced convolution operations. In one embodiment, the set of parameters includes a displacement vector and at least one convolution kernel per pixel. Generating a pixel value in the next video frame includes applying the convolution kernel to a corresponding patch of pixels in the previous video frame based on the displacement vector.

Abstract: Provided are novel methods and compositions for administration of pharmaceuticals to subjects with dysphagia. Pharmaceuticals are associated with beads and administered with food, beverage or cosmetic to provide ease of administration to subjects with dysphagia. Environmental indicators are associated with beads for Quality Assurance.

Abstract: The invention provides methods and compositions for the treatment of a skin disorder associated with detrimental TNF? activity, such as psoriasis. The invention includes methods for treating a skin disorder associated with detrimental TNF? activity, such as psoriasis, in a subject who has failed or lost response to prior biologic therapy, such as prior administration of etanercept. The invention further provides methods for determining the efficacy of a human TNF? antibody, or antigen-binding portion thereof, for the treatment of a skin disorder associated with detrimental TNF? activity, such as psoriasis.

Abstract: Provided are novel methods and compositions for administration of pharmaceuticals to subjects with dysphagia. Pharmaceuticals are associated with beads and administered with food, beverage or cosmetic to provide ease of administration to subjects with dysphagia. Environmental indicators are associated with beads for Quality Assurance.

Abstract: The invention provides methods and compositions for the treatment of a skin disorder associated with detrimental TNF? activity, such as psoriasis. The invention includes methods for treating a skin disorder associated with detrimental TNF? activity, such as psoriasis, in a subject who has failed or lost response to prior biologic therapy, such as prior administration of etanercept. The invention further provides methods for determining the efficacy of a human TNF? antibody, or antigen-binding portion thereof, for the treatment of a skin disorder associated with detrimental TNF? activity, such as psoriasis.

Abstract: The invention relates to the identification of the ovo-like zinc finger 1 (OVOL1) as a new biomarker of moderate to severe acne. The invention also relates to products and methods for detecting, diagnosing, staging, treating or monitoring the course of acne in a human subject.

Abstract: The invention relates to the identification of Adaptor-Related Protein Complex 5, subunit 1 (AP5B1) as a biomarker of moderate to severe acne. The invention also relates to products and methods for detecting, diagnosing, staging, treating or monitoring the course of acne in a human subject.

Abstract: Provided are novel methods and compositions for administration of pharmaceuticals to subjects with dysphagia. Pharmaceuticals are associated with beads and administered with food, beverage or cosmetic to provide ease of administration to subjects with dysphagia. Environmental indicators are associated with beads for Quality Assurance.

Abstract: The invention provides methods and compositions for the treatment of a skin disorder associated with detrimental TNF? activity, such as psoriasis. The invention includes methods for treating a skin disorder associated with detrimental TNF? activity, such as psoriasis, in a subject who has failed or lost response to prior biologic therapy, such as prior administration of etanercept. The invention further provides methods for determining the efficacy of a human TNF? antibody, or antigen-binding portion thereof, for the treatment of a skin disorder associated with detrimental TNF? activity, such as psoriasis.